Literature DB >> 10455044

Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

K Paradis1, G Langford, Z Long, W Heneine, P Sandstrom, W M Switzer, L E Chapman, C Lockey, D Onions, E Otto.   

Abstract

Pig organs may offer a solution to the shortage of human donor organs for transplantation, but concerns remain about possible cross-species transmission of porcine endogenous retrovirus (PERV). Samples were collected from 160 patients who had been treated with various living pig tissues up to 12 years earlier. Reverse transcription-polymerase chain reaction (RT-PCR) and protein immunoblot analyses were performed on serum from all 160 patients. No viremia was detected in any patient. Peripheral blood mononuclear cells from 159 of the patients were analyzed by PCR using PERV-specific primers. No PERV infection was detected in any of the patients from whom sufficient DNA was extracted to allow complete PCR analysis (97 percent of the patients). Persistent microchimerism (presence of donor cells in the recipient) was observed in 23 patients for up to 8.5 years.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455044     DOI: 10.1126/science.285.5431.1236

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  120 in total

1.  Certain promise and uncertain peril. The debate on xenotransplantation.

Authors:  R A Weiss
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

2.  Xenotransplantation. This new form of treatment might benefit millions.

Authors:  D K Cooper; C G Groth; I F McKenzie
Journal:  BMJ       Date:  2000-03-25

Review 3.  Xenotransplantation--2000.

Authors:  M J Goddard; J E Foweraker; J Wallwork
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

4.  Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses.

Authors:  S K Powell; M E Gates; G Langford; M L Gu; C Lockey; Z Long; E Otto
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

5.  Infection in xenotransplantation.

Authors:  J A Fishman
Journal:  BMJ       Date:  2000-09-23

6.  Starting clinical trials of xenotransplantation--reflections on the ethics of the early phase.

Authors:  S Welin
Journal:  J Med Ethics       Date:  2000-08       Impact factor: 2.903

Review 7.  Xenotransplantation: where are we today?

Authors:  M D Dooldeniya; A N Warrens
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 5.344

8.  Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells.

Authors:  U Krach; N Fischer; F Czauderna; R R Tönjes
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 9.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

10.  Characterization of endogenous retroviruses in pig cell cultures.

Authors:  M Ferrari; M N Losio; A Corradi; S Vittori; A Tosini
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.